jcm-logo

Journal Browser

Journal Browser

Challenges and Innovations in Thrombosis and Haemostasis

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Vascular Medicine".

Deadline for manuscript submissions: 20 March 2026 | Viewed by 288

Special Issue Editors


E-Mail Website
Guest Editor
School of Medicine, European University Cyprus, 2404 Nicosia, Cyprus
Interests: hematology; venous thromboembolism; thrombosis; risk assessment models; artificial intelligence; bioethics

E-Mail Website
Guest Editor
Blood Center, AHEPA University Hospital, Thessaloniki, Greece
Interests: thrombosis and hemostasis; thrombophilia; antiphospholipid syndrome

Special Issue Information

Dear Colleagues,

Thrombosis and haemostasis disorders remain major contributors to global morbidity and mortality, with ongoing challenges in optimizing prevention, diagnosis, and management across diverse patient populations. Despite therapeutic advances, key clinical dilemmas persist—particularly in complex scenarios such as pregnancy, pediatrics, malignancy, and antiphospholipid syndrome. Moreover, the development of safer, more effective antithrombotic regimens tailored to individual risk profiles is urgently needed.

At the same time, innovations in artificial intelligence, digital health tools, and biomedical devices are opening new frontiers in thrombosis care—from personalized risk prediction to real-time monitoring and clinical decision support. As these technologies are increasingly adopted, ethical, regulatory, and practical implementation issues must also be addressed.

This Special Issue, "Challenges and Innovations in Thrombosis and Haemostasis", invites original research and review articles that explore novel diagnostic and predictive tools, antithrombotic strategies, management in special populations, and the integration of emerging technologies. Contributions that critically examine ethical challenges in the evolving landscape of thrombosis care are also welcome.

We look forward to your submissions that will help shape the future of this dynamic and impactful field.

Dr. Vasiliki Danilatou
Dr. Fotios I. Girtovitis
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • air pollution and thrombosis
  • antiphospholipid syndrome
  • antithrombotic therapy
  • arterial thrombosis
  • artificial intelligence in thrombosis and haemostasis
  • biology of arterial thrombosis
  • biomarkers in thrombosis and haemostasis
  • cancer-associated thrombosis
  • clinical decision support
  • current concepts and novel targets for antiplatelet treatments
  • digital health in heamostasis and thrombosis
  • endotheliopathy and thrombosis
  • ethical challenges in thrombosis care
  • hemophilia and von willebrand disease
  • innovative therapies in thrombosis and haemostasis
  • pediatric thrombosis
  • platelet biology and function: new concepts and clinical perspectives
  • rare blood disorders
  • thrombophilia
  • thrombosis and hemostasis guidelines
  • thrombosis in pregnancy
  • thrombo-inflammation
  • trauma-induced coagulopathy
  • venous thromboembolism

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop